- $2.29bn
- $5.18bn
- $4.25bn
Perrigo Company PLC reports results for the quarter ended June 30 - Earnings Summary
Brief: Perrigo Company Reaffirms Full-Year 2026 Outlook
Ireland's Perrigo Q2 profit beats on portfolio streamlining
Brief: Perrigo Company - Declares QTRLY Dividend Of $0.29 Per Share
Brief: Perrigo Announces Appointment Of Two New Independent Directors To Board
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj
U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental
Perrigo CEO dismissed over personal conduct, shares fall
Press Digest: Wall Street Journal - June 9
Perrigo Q1 revenue falls 7%, misses estimates amid weak demand
Ireland's Perrigo Q4 revenue slightly beats
Perrigo begins strategic review of baby formula business
Perrigo Q3 net sales miss estimates
Drugmakers must face skincare drug price-fixing lawsuit, US judge rules
Brief: Teamsters Says Local 210 Members At Perrigo’S Bronx Production Facility Ratified New 3-Year Contract
Brief: Perrigo Teamsters In New York Launch Strike
Perrigo Company PLC reports results for the quarter ended June 30 - Earnings Summary
Drugmaker Perrigo misses Q2 sales estimates, cautions on FY forecast